Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.099 AUD | +2.06% | +4.26% | -10.91% |
04-22 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
04-22 | PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study | MT |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Andrew Taylor
DFI | Director of Finance/CFO | - | - |
Kevin Hart
DFI | Director of Finance/CFO | 62 | 17-07-23 |
Paula Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sue Fletcher
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Sri Mudumba
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 21-03-16 | |
Jason Haddock
BRD | Director/Board Member | 54 | 21-03-28 |
Alan W. Tribe
CHM | Chairman | 76 | 18-04-10 |
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,732,867,135 | 1,770,806,760 ( 47.44 %) | 0 | 47.44 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.91% | 270M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- PYC Stock
- Company PYC Therapeutics Limited